Search and Filter
Results per Page:
Fred Hutch researchers look at longevity in older women, metabolic signatures of vaginitis
Two prestigious R01 NIH grants awarded to Drs. Alex Reiner, Sujatha Srinivasan
Meet the people behind some of Fred Hutch’s breakthroughs, because discovery has a first name
Fred Hutch’s world-changing work is also personal
A second opinion changed everything
After an unexpected diagnosis of throat cancer, a patient found a treatment that helped him beat cancer and preserve his quality of life
When both cancer and courage run in the family
Two Seattle sisters, both diagnosed with BRCA2-driven breast cancer, speak out on importance of genetic testing for hereditary cancers
It ends with her
An inherited gene mutation upended Amanda Swenson’s life. She gives to ensure her daughter has a healthier future
Making the smallest machines of life big enough to hold in your hands
In this episode of In the Lab, learn how Dr. Matthew Ross uses a 3D printer to solve problems for Fred Hutch researchers
A potential game-changer in blood and marrow transplantation
Dr. Marco Mielcarek will collaborate with researchers across three institutions to improve preventative care for graft-vs.-host disease
Support groups can be a valuable tool in recovering from cancer
All proton therapy facility patients — past, present and future — are welcome
From tow trucks to health care: meet our new patient care coordinator
Proof that helping others comes in many forms
Prostate cancer genetics, germline testing and expanding access with Dr. Heather Cheng
Oncology Insights with Dr. Petros Grivas - Episode 22
Study uncovers genomic architecture and natural history of metastatic bladder cancer
Published in Nature, a new study using a first-in-kind rapid autopsy program shows details of metastatic bladder cancer subtypes; could improve diagnosis and future treatment
Study supports effectiveness of RSV preventive antibody treatments for infants and provides new way to monitor viral resistance
Analysis published in Nature of more than 60,000 RSV sequences found resistance-associated variants to two monoclonal antibody treatments are rare and provides a roadmap to help guide the development of future prevention tools.
New assay better predicts treatment for two cancers
Fred Hutch researchers develop HRDefine, a new clinical test to better serve patients with tubo-ovarian and triple-negative breast cancer
Exploring the health impacts of sickle cell trait
A new analysis could expand our understanding of the health conditions associated with a single copy of the sickle cell beta globin gene
Living with the long-term side effects of prostate cancer, from sexual to spiritual
In this episode of Bench to Bedside and Beyond, we talk to a prostate cancer patient and the director of the Fred Hutch Sexual Health Clinic
Dr. Molly Tokaz on thoracic oncology, veterans' cancer care and educating the next generation
Oncology Insights with Dr. Petros Grivas - Episode 21
Unraveling how immune aging influences health outcomes for survivors of childhood blood cancers
Fred Hutch pediatric immunologist’s R01 will support search for therapeutic targets to stave off cardiovascular disease and other aging-associated conditions
Fred Hutch Cancer Center to lead $15 million national clinical trial initiative for older adults with acute myeloid leukemia
A new five-year funding award led by Fred Hutch physician and stem cell transplant expert Mohamed Sorror, MD, MS, from the Patient-Centered Outcomes Research Institute (PCORI) will support three national randomized trials